Last reviewed · How we verify

NCT06720623

Diagnostic Power of Basal LH Compared to Peak LH After Stimulus Test in the Diagnosis of Central Precocious Puberty

Completed Last updated 6 December 2024
What this trial tests

trial in Central Precocious Puberty (CPP) in 213 participants. Completed in 31 December 2023.

Timeline
25 May 2021
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
StatusCompleted
Study typeOBSERVATIONAL
Enrollment213
Start date25 May 2021
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Italy

Conditions studied

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna — full company profile →

Who can join

Under 8, female only, with Central Precocious Puberty (CPP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, retrospective, single-center study focused on the diagnosis of Central Precocious Puberty in female patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Central Precocious Puberty (CPP)

Currently open trials in the same condition.

Other IRCCS Azienda Ospedaliero-Universitaria di Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06720623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing